"10.1371_journal.pone.0083914","plos one","2013-12-26T00:00:00Z","Irina Lonskaya; Nicole M Desforges; Michaeline L Hebron; Charbel E-H Moussa","Department of Neuroscience, Laboratory for Dementia and Parkinsonism, Georgetown University Medical Center, Washington, DC, United States of America","Conceived and designed the experiments: CM. Performed the experiments: CM IL ND MH. Analyzed the data: CM IL ND MH. Wrote the paper: CM.","Dr. Charbel Moussa has a pending application to use nilotinib and bosutinib as a treatment for neurodegenerative diseases. The PCT application number PCT/US13/039283 was filed on May 2, 2013 and claims priority to two provisional patent applications filed on May 2, 2012 and March 1, 2013. The title is “Treating neural diseases with tyrosine kinase inhibitors.” The authors also confirm that they adhere to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","12","Irina Lonskaya","IL",4,TRUE,1,4,4,1,TRUE,TRUE,FALSE,0,NA,FALSE
